Lundbeck Says It Won't Need a Big Buy After Trial Failure

(Bloomberg) -- H. Lundbeck A/S has an early answer for those wondering how it will ever plug the future sales hole that emerged when its once-promising schizophrenia drug failed a key trial.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.